AVITA Medical (NASDAQ:RCEL) Given "Overweight" Rating at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of AVITA Medical (NASDAQ:RCEL – Free Report) in a report issued on Thursday, Benzinga reports. They currently have a $26.00 price objective on the stock. RCEL has been the topic of a number of other research reports. Bank of America boosted their target price on shares of […]
Source: etfdailynews.com